Seattle Genetics
-
Ticker
SGEN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 501-1000 Employees
- Based in Bothell, Washington
Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States.
REPORT RATINGS
5.0 / 5.0 (1)
Seattle Genetics reports have an aggregate usefulness score of 5.0 based on 1 reviews.
Seattle Genetics
Most Recent Responsibility Report
MOST RECENT
2022 Corporate Responsibility Report
Our service enables potential investors to review the most recent and archived Seattle Genetics Sustainability Report, Seattle Genetics Corporate Social Responsibility Report, Seattle Genetics CSR Report, Seattle Genetics Corporate Responsibility, Seattle Genetics CR Report, Seattle Genetics Citizenship Report, Seattle Genetics ESG Report, and Seattle Genetics Environmental Report online.